- Report
- March 2024
- 186 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 182 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- January 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- April 2024
- 137 Pages
Global
From €3749EUR$3,899USD£3,216GBP
- Report
- October 2023
- 190 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1202EUR$1,250USD£1,031GBP
- Report
- July 2023
- 118 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- March 2022
- 300 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- August 2022
- 120 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- March 2021
Global
From €3846EUR$4,000USD£3,299GBP
- Report
- November 2023
- 250 Pages
Global
From €5510EUR$5,730USD£4,727GBP
- Report
- May 2023
- 160 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Book
- September 2023
- 288 Pages
- Book
- August 2022
- 560 Pages
Anthelmintic drugs are used to treat parasitic worm infections, such as roundworm, hookworm, and whipworm. These drugs are used to treat a variety of conditions, including gastrointestinal, respiratory, and skin infections. Anthelmintic drugs work by killing the worms or preventing them from reproducing. They can also be used to prevent reinfection.
Anthelmintic drugs are part of the larger market of infectious disease drugs, which includes antibiotics, antivirals, and antifungals. These drugs are used to treat a wide range of infectious diseases, from common colds to more serious conditions such as HIV/AIDS.
The anthelmintic market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, Bayer, and Novartis. These companies offer a range of products, from generic drugs to more specialized treatments. Show Less Read more
